MD Hans H Hirsch
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation
Wójtowicz A, Maja W, Mueller N, Meylan P, Steiger J, Kutalik Z, Pascual M, Van Delden C, van de Veerdonk F, Bochud P, Hirsch H, Garzoni C, Gresnigt M, Lecompte T, Bibert S, Manuel O, Joosten L, Rüeger S, Christoph B, Boggian K, Cusini A. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation. J Infect Dis 2014; 211:1646-57.
14.11.2014IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation
14.11.2014J Infect Dis 2014; 211:1646-57
Wójtowicz Agnieszka, Maja Weisser, Mueller Nicolas J, Meylan Pascal R, Steiger Jürg, Kutalik Zoltán, Pascual Manuel, Van Delden Christian, van de Veerdonk Frank L, Bochud Pierre-Yves, Hirsch Hans H, Garzoni Christian, Gresnigt Mark S, Lecompte Thanh, Bibert Stéphanie, Manuel Oriol, Joosten Leo A B, Rüeger Sina, Christoph Berger, Boggian Katia, Cusini Alexia
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation
Manuel O, Swiss Transplant Cohort Study (STCS), Bochud P, Pascual M, Meylan P, Cusini A, Christoph B, Maja W, Binet F, Garzoni C, Egli A, Stern M, Steiger J, Hirsch H, Van Delden C, Mueller N, Bibert S, Wójtowicz A, Swiss Transplant Cohort Study STCS. Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation. J Infect Dis 2014; 211:906-14.
09.10.2014Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation
09.10.2014J Infect Dis 2014; 211:906-14
Manuel Oriol, Swiss Transplant Cohort Study (STCS), Bochud Pierre-Yves, Pascual Manuel, Meylan Pascal, Cusini Alexia, Christoph Berger, Maja Weisser, Binet Françoise-Isabelle, Garzoni Christian, Egli Adrian, Stern Martin, Steiger Juerg, Hirsch Hans H, Van Delden Christian, Mueller Nicolas J, Bibert Stéphanie, Wójtowicz Agnieszka, Swiss Transplant Cohort Study STCS
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Metzner K, Günthard H, Weber R, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Hirsch H, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, von Wyl V, Scherrer A, the Swiss HIV Cohort Study. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS 2014; 28:2231-2239.
24.09.2014Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
24.09.2014AIDS 2014; 28:2231-2239
Metzner Karin J, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Hirsch Hans H, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Scherrer Alexandra U, the Swiss HIV Cohort Study
Relevance of cohort studies for the study of transplant infectious diseases
Christoph B, Mueller N, Maja W, Nadal D, Meylan P, Manuel O, Koller M, Khanna N, Hirsch H, Garzoni C, Van Delden C, Cusini A, Boggian K, Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 2012; 17:581-585.
01.12.2012Relevance of cohort studies for the study of transplant infectious diseases
01.12.2012Curr Opin Organ Transplant 2012; 17:581-585
Christoph Berger, Mueller Nicolas J, Maja Weisser, Nadal David, Meylan Pascal, Manuel Oriol, Koller Michael, Khanna Nina, Hirsch Hans H, Garzoni Christian, Van Delden Christian, Cusini Alexia, Boggian Katia, Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study
Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients
Manuel O, Pascual M, Cusini A, Boggian K, Christoph B, Van Delden C, Maja W, Hirsch H, Garzoni C, Müller N, Kralidis G, Meylan P (2012). Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients.
02.06.2012Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients
02.06.2012American Transplant Congress
Manuel Oriol, Pascual Manuel, Cusini Alexia, Boggian Katia, Christoph Berger, Van Delden Christian, Maja Weisser, Hirsch Hans H, Garzoni Christian, Müller Nicolas J, Kralidis Georg, Meylan Pascal
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Fehr J, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard H, Battegay M, Bucher H, Klimkait T, Fux C, Cavassini M, Glass T, Louvel S, Hamy F, Hirsch H, von Wyl V, Böni J, Yerly S, Bürgisser P, Hiv Cohort Study A. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 2011; 9:14.
21.01.2011Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
21.01.2011J Transl Med 2011; 9:14
Fehr Jan, Hirschel Bernard, Vernazza Pietro, Martinetti Gladys, Bernasconi Enos, Günthard Huldrych F, Battegay Manuel, Bucher Heiner C, Klimkait Thomas, Fux Christoph A, Cavassini Matthias, Glass Tracy R, Louvel Severine, Hamy Francois, Hirsch Hans H, von Wyl Viktor, Böni Jürg, Yerly Sabine, Bürgisser Philippe, Hiv Cohort Study And The Swiss
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
15.05.2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
15.05.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
Khanna N, Hirsch H, Battegay M, Viscidi R, Bernasconi E, Vernazza P, Fux C, Du Pasquier R, Garzoni C, Mueller N, Wolbers M, Swiss HIV Cohort Study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of virology 2009; 83:4404-11.
01.05.2009JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
01.05.2009Journal of virology 2009; 83:4404-11
Khanna Nina, Hirsch Hans H, Battegay Manuel, Viscidi Raphael, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Du Pasquier Renaud A, Garzoni Christian, Mueller Nicolas J, Wolbers Marcel, Swiss HIV Cohort Study
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Mueller N, Erb P, Steffen I, Cathomas G, Baumann M, Gayet-Ageron A, Toutous-Trellu L, Swiss HIV Cohort Study. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS (London, England) 2008; 22:1019-28.
31.05.2008Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
31.05.2008AIDS (London, England) 2008; 22:1019-28
El Amari Emmanuelle Boffi, Hirschel Bernard, Bernasconi Enos, Hirsch Hans H, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Mueller Nicolas J, Erb Peter, Steffen Ingrid, Cathomas Gieri, Baumann Michele, Gayet-Ageron Angèle, Toutous-Trellu Laurence, Swiss HIV Cohort Study
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
Egli A, Sester M, Sester U, Steiger J, Schaub S, Dumoulin A, Jäger C, Binggeli S, Binet F, Hirsch H. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. Journal of translational medicine 2008; 6:29.
01.01.2008Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
01.01.2008Journal of translational medicine 2008; 6:29
Egli Adrian, Sester Martina, Sester Urban, Steiger Juerg, Schaub Stefan, Dumoulin Alexis, Jäger Clemens, Binggeli Simone, Binet Françoise-Isabelle, Hirsch Hans H
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification
Keiser O, Furrer H, Telenti A, Rickenbach M, Vernazza P, Bernasconi E, Hirschel B, Hirsch H, Opravil M, Fellay J, Swiss HIV Cohort Study. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antiviral therapy 2007; 12:1157-64.
01.01.2007Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification
01.01.2007Antiviral therapy 2007; 12:1157-64
Keiser Olivia, Furrer Hansjakob, Telenti Amalio, Rickenbach Martin, Vernazza Pietro, Bernasconi Enos, Hirschel Bernard, Hirsch Hans H, Opravil Milos, Fellay Jacques, Swiss HIV Cohort Study
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
Fagard C, Hirschel B, Perrin L, Perneger T, Oxenius A, Ebnöther C, Telenti A, Bernasconi E, Vernazza P, Egger M, Hirsch H, Günthard H, Le Braz M, Swiss HIV Cohort Study. A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS (London, England) 2003; 17:1487-92.
04.07.2003A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
04.07.2003AIDS (London, England) 2003; 17:1487-92
Fagard Catherine, Hirschel Bernard, Perrin Luc, Perneger Thomas, Oxenius Annette, Ebnöther Corinna, Telenti Amalio, Bernasconi Enos, Vernazza Pietro, Egger Martin, Hirsch Hans H, Günthard Huldrych, Le Braz Michelle, Swiss HIV Cohort Study